Nuveen Asset Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $6.86M | Buy |
3,119,253
+1,020,243
| +49% | +$2.24M | ﹤0.01% | 1819 |
|
|
2024
Q3 | $3.46M | Sell |
2,099,010
-173,618
| -8% | -$286K | ﹤0.01% | 2162 |
|
|
2024
Q2 | $5.05M | Buy |
+2,272,628
| New | +$5.05M | ﹤0.01% | 1950 |
|
|
2023
Q2 | – | Sell |
-792,772
| Closed | -$1.26M | – | 3215 |
|
|
2023
Q1 | $1.26M | Sell |
792,772
-226,424
| -22% | -$360K | ﹤0.01% | 2517 |
|
|
2022
Q4 | $6.35M | Buy |
1,019,196
+717,837
| +238% | +$4.47M | ﹤0.01% | 1781 |
|
|
2022
Q3 | $2.02M | Buy |
301,359
+106,392
| +55% | +$713K | ﹤0.01% | 2400 |
|
|
2022
Q2 | $1.24M | Sell |
194,967
-145,932
| -43% | -$928K | ﹤0.01% | 2692 |
|
|
2022
Q1 | $1.89M | Buy |
340,899
+261,772
| +331% | +$1.45M | ﹤0.01% | 2531 |
|
|
2021
Q4 | $395K | Sell |
79,127
-18,987
| -19% | -$94.8K | ﹤0.01% | 3126 |
|
|
2021
Q3 | $1.23M | Sell |
98,114
-67,884
| -41% | -$848K | ﹤0.01% | 2910 |
|
|
2021
Q2 | $3.51M | Sell |
165,998
-48,136
| -22% | -$1.02M | ﹤0.01% | 2425 |
|
|
2021
Q1 | $6.01M | Buy |
214,134
+95,919
| +81% | +$2.69M | ﹤0.01% | 2086 |
|
|
2020
Q4 | $3.07M | Sell |
118,215
-8,144
| -6% | -$212K | ﹤0.01% | 2293 |
|
|
2020
Q3 | $4.7M | Sell |
126,359
-38,767
| -23% | -$1.44M | ﹤0.01% | 1951 |
|
|
2020
Q2 | $8.47M | Sell |
165,126
-19,221
| -10% | -$986K | ﹤0.01% | 1595 |
|
|
2020
Q1 | $5.81M | Buy |
184,347
+20,371
| +12% | +$642K | ﹤0.01% | 1621 |
|
|
2019
Q4 | $9.78M | Sell |
163,976
-125,700
| -43% | -$7.5M | ﹤0.01% | 1601 |
|
|
2019
Q3 | $10.6M | Sell |
289,676
-95,068
| -25% | -$3.49M | ﹤0.01% | 1534 |
|
|
2019
Q2 | $17.9M | Buy |
+384,744
| New | +$17.9M | 0.01% | 1222 |
|